Found 0 matching trials
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma PHASE3 Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion PHASE3 The goal of this clinical trial is to learn if N acetyl cysteine and vitami...
Show More Status
Active Not Recruiting
Location
Ain Shams University
Learn More & Join Trial
Efficacy Study of TKcell in Advanced Gastric Cancer PHASE1 The purpose of this study is to determine efficacy of NKCell combined FOLFO...
Show More Location
The catholic University of korea
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) PHASE1 The purpose of this study is to assess the efficacy, safety, and tolerabili...
Show More Status
Active Not Recruiting
Location
Northwestern Memorial Hospital ( Site 0002)
Learn More & Join Trial
Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study N/A This is a comparative retrospective study of the efficacy of platelet-rich ...
Show More Location
Multiple Locations
Learn More & Join Trial
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. PHASE1 ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody d...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma PHASE1 RATIONALE: Vandetanib may stop the growth of cancer cells by blocking some ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years PHASE2 Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Show More Location
Saint Louis hospital
Learn More & Join Trial